...
ibio-img

Ibio Inc, Common Stock

IBIO

ASQ

$2.36

-$0.12

(-4.84%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$23.30M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
52.91K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-3.37
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.02 L
$4.98 H
$2.36

About Ibio Inc, Common Stock

iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameIBIOSectorS&P500
1-Week Return0.43%-0.94%-2.6%
1-Month Return-7.81%-5.08%-1.08%
3-Month Return27.57%-10.62%3.45%
6-Month Return12.92%-6.18%8.57%
1-Year Return67.38%1.98%24.3%
3-Year Return-99.29%-0.93%25.58%
5-Year Return-98.07%33.84%84.07%
10-Year Return-99.93%102.52%185.12%

Financials

Jun '20Jun '21Jun '22Jun '23Jun '245YR TREND
Total Revenue1.64M2.37M2.38M50.00K225.00K[{"date":"2020-06-30","value":68.74,"profit":true},{"date":"2021-06-30","value":99.5,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":2.1,"profit":true},{"date":"2024-06-30","value":9.44,"profit":true}]
Cost of Revenue703.00K1.46M216.00K1.11M1.25M[{"date":"2020-06-30","value":48.08,"profit":true},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":14.77,"profit":true},{"date":"2023-06-30","value":75.65,"profit":true},{"date":"2024-06-30","value":85.5,"profit":true}]
Gross Profit935.00K909.00K2.17M50.00K225.00K[{"date":"2020-06-30","value":43.15,"profit":true},{"date":"2021-06-30","value":41.95,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":2.31,"profit":true},{"date":"2024-06-30","value":10.38,"profit":true}]
Gross Margin57.08%38.34%90.94%100.00%100.00%[{"date":"2020-06-30","value":57.08,"profit":true},{"date":"2021-06-30","value":38.34,"profit":true},{"date":"2022-06-30","value":90.94,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Operating Expenses15.64M32.02M51.86M29.34M16.86M[{"date":"2020-06-30","value":30.16,"profit":true},{"date":"2021-06-30","value":61.75,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":56.58,"profit":true},{"date":"2024-06-30","value":32.51,"profit":true}]
Operating Income(14.00M)(31.11M)(49.69M)(29.31M)(16.63M)[{"date":"2020-06-30","value":-1400300000,"profit":false},{"date":"2021-06-30","value":-3111100000,"profit":false},{"date":"2022-06-30","value":-4969000000,"profit":false},{"date":"2023-06-30","value":-2931100000,"profit":false},{"date":"2024-06-30","value":-1663400000,"profit":false}]
Total Non-Operating Income/Expense(4.89M)5.58M(1.05M)32.00K1.38M[{"date":"2020-06-30","value":-87.61,"profit":false},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":-18.8,"profit":false},{"date":"2023-06-30","value":0.57,"profit":true},{"date":"2024-06-30","value":24.75,"profit":true}]
Pre-Tax Income(16.44M)(23.21M)(50.30M)(29.31M)(15.44M)[{"date":"2020-06-30","value":-1644400000,"profit":false},{"date":"2021-06-30","value":-2321300000,"profit":false},{"date":"2022-06-30","value":-5030400000,"profit":false},{"date":"2023-06-30","value":-2931100000,"profit":false},{"date":"2024-06-30","value":-1544300000,"profit":false}]
Income Taxes2.47M46.00K701.00K(1.20M)9.64M[{"date":"2020-06-30","value":25.64,"profit":true},{"date":"2021-06-30","value":0.48,"profit":true},{"date":"2022-06-30","value":7.27,"profit":true},{"date":"2023-06-30","value":-12.49,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]
Income After Taxes(18.91M)(23.26M)(51.01M)(28.11M)(25.08M)[{"date":"2020-06-30","value":-1891500000,"profit":false},{"date":"2021-06-30","value":-2325900000,"profit":false},{"date":"2022-06-30","value":-5100500000,"profit":false},{"date":"2023-06-30","value":-2810700000,"profit":false},{"date":"2024-06-30","value":-2507900000,"profit":false}]
Income From Continuous Operations(16.44M)(23.21M)(50.30M)(29.31M)(15.44M)[{"date":"2020-06-30","value":-1644400000,"profit":false},{"date":"2021-06-30","value":-2321300000,"profit":false},{"date":"2022-06-30","value":-5030400000,"profit":false},{"date":"2023-06-30","value":-2931100000,"profit":false},{"date":"2024-06-30","value":-1544300000,"profit":false}]
Income From Discontinued Operations(20.79M)(20.79M)(20.79M)(35.70M)-[{"date":"2020-06-30","value":-2079100000,"profit":false},{"date":"2021-06-30","value":-2079100000,"profit":false},{"date":"2022-06-30","value":-2079100000,"profit":false},{"date":"2023-06-30","value":-3569900000,"profit":false},{"date":"2024-06-30","value":"-","profit":true}]
Net Income(18.91M)(23.26M)(51.01M)(29.31M)(24.91M)[{"date":"2020-06-30","value":-1891500000,"profit":false},{"date":"2021-06-30","value":-2325900000,"profit":false},{"date":"2022-06-30","value":-5100500000,"profit":false},{"date":"2023-06-30","value":-2931100000,"profit":false},{"date":"2024-06-30","value":-2490700000,"profit":false}]
EPS (Diluted)-(4.20)(5.71)(3.33)(6.42)[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":-420,"profit":false},{"date":"2022-06-30","value":-571,"profit":false},{"date":"2023-06-30","value":-333.32,"profit":false},{"date":"2024-06-30","value":-641.99,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

IBIO
Cash Ratio 3.18
Current Ratio 3.37

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IBIO
ROA (LTM) -29.73%
ROE (LTM) -84.15%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IBIO
Debt Ratio Lower is generally better. Negative is bad. 0.28
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.72

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IBIO
Trailing PE NM
Forward PE NM
P/S (TTM) 129.66
P/B 1.28
Price/FCF NM
EV/R 90.78
EV/Ebitda NM
PEG NM

FAQs

What is Ibio Inc share price today?

Ibio Inc (IBIO) share price today is $2.36

Can Indians buy Ibio Inc shares?

Yes, Indians can buy shares of Ibio Inc (IBIO) on Vested. To buy Ibio Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Ibio Inc be purchased?

Yes, you can purchase fractional shares of Ibio Inc (IBIO) via the Vested app. You can start investing in Ibio Inc (IBIO) with a minimum investment of $1.

How to invest in Ibio Inc shares from India?

You can invest in shares of Ibio Inc (IBIO) via Vested in three simple steps:

  • Click on Sign Up or Invest in IBIO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Ibio Inc shares
What is Ibio Inc 52-week high and low stock price?

The 52-week high price of Ibio Inc (IBIO) is $4.98. The 52-week low price of Ibio Inc (IBIO) is $1.02.

What is Ibio Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Ibio Inc (IBIO) is

What is Ibio Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Ibio Inc (IBIO) is 1.28

What is Ibio Inc dividend yield?

The dividend yield of Ibio Inc (IBIO) is 0.00%

What is the Market Cap of Ibio Inc?

The market capitalization of Ibio Inc (IBIO) is $23.30M

What is Ibio Inc’s stock symbol?

The stock symbol (or ticker) of Ibio Inc is IBIO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top